Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 037599/0484 | |
| Pages: | 3 |
| | Recorded: | 01/27/2016 | | |
| Attorney Dkt #: | IRM CERTIFICATE OF MERGER |
| Conveyance: | MERGER AND CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
7
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/09/2008
|
Application #:
|
10849450
|
Filing Dt:
|
05/19/2004
|
|
Publication #:
|
|
Pub Dt:
|
01/13/2005
| | | | |
|
Title:
|
IMMUNOSUPPRESSANT COMPOUNDS AND COMPOSITIONS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/26/2008
|
Application #:
|
10849458
|
Filing Dt:
|
05/19/2004
|
|
Publication #:
|
|
Pub Dt:
|
01/20/2005
| | | | |
|
Title:
|
IMMUNOSUPPRESSANT COMPOUNDS AND COMPOSITIONS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/10/2011
|
Application #:
|
12024992
|
Filing Dt:
|
02/01/2008
|
|
Publication #:
|
|
Pub Dt:
|
02/05/2009
| | | | |
|
Title:
|
IMMUNOSUPPRESANT COMPOUNDS AND COMPOSITIONS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/06/2010
|
Application #:
|
12180479
|
Filing Dt:
|
07/25/2008
|
|
Publication #:
|
|
Pub Dt:
|
05/21/2009
| | | | |
|
Title:
|
IMMUNOSUPPRESSANT COMPOUNDS AND COMPOSITIONS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/13/2013
|
Application #:
|
12663490
|
Filing Dt:
|
04/05/2010
|
|
Publication #:
|
|
Pub Dt:
|
08/05/2010
| | | | |
|
Title:
|
BIPHENYLCARBOXAMIDE DERIVATIVES AS HEDGEHOD PATHWAY MODULATORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/14/2017
|
Application #:
|
13985342
|
Filing Dt:
|
10/18/2013
|
|
Publication #:
|
|
Pub Dt:
|
02/06/2014
| | | | |
|
Title:
|
DIRECTED DIFFERENTIATION OF OLIGODENDROCYTE PRECURSOR CELLS TO A MYELINATING CELL FATE
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
14380776
|
Filing Dt:
|
08/25/2014
|
|
Publication #:
|
|
Pub Dt:
|
05/07/2015
| | | | |
|
Title:
|
CANCER PATIENT SELECTION FOR ADMINISTRATION OF Wnt SIGNALING INHIBITORS USING RNF43 MUTATION STATUS
|
|
|
Assignors
|
|
|
|
|
|
|
|
|
|
Newly Merged Entity Data
|
|
|
|
|
|
Newly Merged Entity's New Name
|
|
|
|
|
| 131 FRONT STREET |
| HAMILTON, BERMUDA HM 12 |
|
|
Correspondence name and address
|
| |
JIM LYNCH
|
| |
NOVARTIS PHARMACEUTICALS CORPORATION
|
| |
ONE HEALTH PLAZA, BLDG 433
|
| |
EAST HANOVER, NJ 07936
|
Search Results as of:
05/21/2024 07:49 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
| 
